Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liposomal Bupivacaine Versus Ropivacaine for Wound Infiltration Analgesia After Milligan-Morgan Open Hemorrhoidectomy: A Randomized Controlled Trial

NCT07795203 is registered in ClinicalTrials.gov with Tongliao City People's Hospital as lead sponsor.

NCT NCT07795203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07795203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liposomal Bupivacaine Versus Ropivacaine for Wound Infiltration Analgesia After Milligan-Morgan Open Hemorrhoidectomy: A Randomized Controlled Trial
Lead sponsor
Tongliao City People's Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 30, 2026
Completion date
September 30, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resting visual analog scale (vas) pain score